Kroatien

Aktuelle eAlerts

•  

  12/04/2024

  Europe

  Navigating clinical trial disclosures: No reasonable expectation of success in a patient sub-population in view of prior art reporting phase III clinical trial (T 1437/21)

  Recent EPO Board of Appeal decision T 1437/21 adds to a growing number of decisions concerning the patentability of second or further medical use inventions where the prior art relates to a clinical trial. At a time when the European Medicines Agency (EMA) is requiring increased transparency for EU clinical trials, this case law is of increasing importance to those operating in the pharmaceutical space.In brief, this decision further supports the position that the disclosure of a clinical trial protocol does not always mean there is a reasonable expectation of success of achieving treatment. The...

  Mehr
•  

  12/04/2024

  International

  Oil & Gas: English court restrains foreign JOA proceedings in breach of arbitration provision

  In The Shell Petroleum Development Company of Nigeria Limited v Sunlink Energies and Resources Limited [2023] EWHC 3135 (Comm), the English Commercial Court demonstrated its willingness to ensure that a joint operating agreement’s arbitration provisions were preserved, and backed by real action by the court for a party seeking to circumvent them.BackgroundThe claimant, Shell Petroleum Development Company of Nigeria Limited (“SPDC”), and the defendant, Sunlink Energies and Resources Limited (“Sunlink”), were parties to a 2005 Joint Operating Agreement (the “JOA”)...

  Mehr
•  

  11/04/2024

  Europe

  Designs practice update: EU Court of Justice upholds Advocate General’s opinion on strict rules for design priority

  BackgroundIn our previous article (here), we discussed the opinion of Advocate General Capeta in EUIPO v The KaiKai Company Jaeger Wichmann. That opinion was provided following an appeal against the General Court’s ruling, which had held that the 12-month patent priority period could be applied to an EU design application claiming priority from a prior-filed PCT.By way of background, the European Intellectual Property Office (“EUIPO”) had rejected a priority claim by KaiKai Company for a Community Design application based on an earlier PCT patent, on the basis that it exceeded...

  Mehr
•  

  09/04/2024

  International

  CMS European M&A Study 2024: Optimism for M&A amid evolving market trends

  The CMS Corporate/M&A Group is pleased to launch the 16th edition of the European M&A Study.It's been a wild ride for mergers and acquisitions (M&A) around the world this year. Yet, despite the turbulence, we are seeing plenty of reasons to be hopeful about M&A activities in Europe for 2024. The resilience shown amidst economic and geopolitical ups and downs is truly inspiring. Our Study dives into an impressive 559 M&A deals that CMS advised in 2023 and reports on deal trends and current market standards on risk allocation.You can download the study here.Key findings:Sustained...

  Mehr
•  

  09/04/2024

  Europe

  The sum of parts: Registered design for segments of towers found valid by General Court

  BackgroundTA Towers ApS (“TA Towers”), a company based in Denmark, is the holder of the below registered Community design relating to goods for building materials, specifically, ‘building materials for a windmill tower’ (the “RCD”): On 3 September 2019, the intervener, Wobben Properties GmbH (Wobben) filed an application for a declaration of invalidity of the RCD. Wobben claimed that:the contested design lacked novelty,it did not have individual character, andthe features of its appearance were solely dictated...

  Mehr
•  

  03/04/2024

  Europe

  EP Case Law in Brief: Long-felt want and inventive step

  “Where the invention solves a technical problem which workers in the art have been attempting to solve for a long time, or otherwise fulfils a long-felt need, this may be regarded as an indication of inventive step.”The EPO Guidelines (G-VII, 10.3) describe the basic approach to the concept of long-felt want or long-felt need – terms that are used interchangeably. Long-felt want is an example of a secondary indicator of inventive step. Secondary indicators are factors which, although on their own may not be enough to indicate an inventive step, may be supportive of inventive step...

  Mehr